Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma

New England Journal of Medicine - Tập 379 Số 1 - Trang 54-63 - 2018
Ghassan K. Abou‐Alfa1, Tim Meyer2, Ann‐Lii Cheng3, Anthony B. El-Khoueiry4, Lorenza Rimassa5, Baek Yeol Ryoo6, İrfan Çiçin7, Philippe Merle8, Yen-Hsun Chen9, Joong‐Won Park10, Jean Frédéric Blanc11, Luigi Bolondi12, Heinz‐Josef Klümpen13, Stephen L. Chan14, Vittorina Zagonel15, Tiziana Pressiani5, Min Hee Ryu6, Alan P. Venook16, Colin Hessel17, Anne E. Borgman-Hagey17, Gisela Schwab17, Robin Kate Kelley16
1Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York
2Royal Free Hospital and University College London, London
3National Taiwan University Hospital, Taipei
4USC Norris Comprehensive Cancer Center, Los Angeles
5Rozzano
6Asan Medical Center, University of Ulsan College of Medicine, Seoul
7Trakya University School of Medicine, Edirne, Turkey
8Groupement Hospitalier Nord, Lyon
9Department of Medical Oncology, Liouying Chi Mei Hospital, Tainan
10National Cancer Center, Goyang
11Hôpital Haut-Lévêque, Centre Hospitalier Universitaire Bordeaux, Bordeaux
12Department of Medical and Surgical Sciences, University of Bologna, Bologna
13Department of Medical Oncology, Academic Medical Center, Amsterdam
14Chinese University of Hong Kong, State Key Laboratory in Oncology in South China, Hong Kong
15Medical Oncology Unit 1, Istituto Oncologico Veneto, IRCCS, Padua
16UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
17Exelixis, Alameda

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1002/ijc.29210

10.1002/cncr.29936

Abou-Alfa GK, Jarnagin W, Lowery M, et al. Liver and bile duct cancer. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff’s clinical oncology. 5th ed. Philadelphia: Saunders, 2014:1373-96.

10.1016/j.jhep.2011.12.001

10.1056/NEJMoa0708857

10.1016/S1470-2045(08)70285-7

10.1016/S0140-6736(16)32453-9

10.1016/S0140-6736(17)31046-2

10.1016/S1470-2045(13)70161-X

10.1016/S1535-6108(03)00085-0

10.3390/cancers8110103

10.1038/nrc3205

10.1038/nrc3847

10.1158/0008-5472.CAN-10-0489

10.1158/2159-8290.CD-11-0240

10.1038/onc.2015.343

10.1002/hep.510250321

10.1371/journal.pone.0154767

10.18632/oncotarget.11621

10.1016/S1470-2045(18)30146-3

10.1158/1078-0432.CCR-13-2620

10.1111/cas.12891

10.1158/1535-7163.MCT-11-0264

10.1093/annonc/mdw651

10.1016/j.ejca.2008.10.026

10.1200/JCO.2012.47.3009

10.1002/sim.4780131308

10.1016/S1470-2045(16)30107-3

10.1056/NEJMoa1510016

Thông tin
Thông tin xuất bản

New England Journal of Medicine

Tập 379 Số 1

54-63

Thông tin tác giả